HIV DNA vaccine (Merck & Co.)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHIV DNA vaccine (Merck & Co.)

Drug Alias NameHuman Immunodeficiency Virus DNA vaccine-Merck & Co

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > Biological material > Viral vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesMerck & Co Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMerck & Co Inc

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A